Yin et al. established that the EZH2 blockade in GBM stimulation promoted the elevation of M1 markers like iNOS and TNF-α as well as the decrease in a pool of M2 markers in murine microglia and human PBMC-derived macrophages (Table 1) [94]. The gene discussed is EZH2; the disease is glioblastoma.